Press Release: Acetylon Pharmaceuticals : Cognitive Impairment Therapeutic Pipeline Review H2 2016 Major Key Players Analysis
Depression - Pipeline Review, H2 2016, provides an overview of the Depression pipeline landscape. The report provides comprehensive information on the therapeutics under development for Depression, complete with analysis by stage of development...
Read full article »
Acetylon Pharmaceuticals intends to manufacture small molecule drugs to realize the therapeutic potential of histone deacetylase.
Read more